Potential Conflict of Interest in the Production of Drug Compendia

White Paper:
Potential Conflict of Interest in the Production of Drug Compendia
PROJECT ID: CMPE1207
April 27, 2009
Duke Evidence-based Practice Center
Duke Center for Clinical Health Policy Research
2200 West Main Street, Suite 220
Durham, NC 27705
(919) 286-3399
Ross McKinney, MD
Amy P. Abernethy, MD
David B. Matchar, MD
Jane L. Wheeler, MSPH

This report is based on research conducted by the Duke Evidence-Based Practice Center under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No HHSA 290 2007 10066-1). The findings and conclusions in this document are those of the author(s) who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. No statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality or of the U.S. Department of Health and Human Services.

The information in this report is intended to help health care decision-makers; patients and clinicians, health system leaders, and policymakers, make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information, i.e., in the context of available resources and circumstances presented by individual patients.

This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
All of the investigators are affiliated with Duke University which is an NCCN Institution. Dr. Abernethy currently serves on the fatigue guideline panel (though this group has no relationship to chemotherapy drugs). There are no other conflicts to disclose.
Copyright Information
White Paper: Potential Conflict of Interest in the Production of Drug Compendia is copyrighted by the Agency for Healthcare Research and Quality (AHRQ). The product and its contents may be used and incorporated into other materials* on the condition that the contents are not changed in any way (including covers and front matter) and that no fee is charged by the reproducer of the product or its contents for its use. The product may not be sold for profit or incorporated into any profit-making venture without the expressed written permission of AHRQ.

Specifically:
• When the document is reprinted, it must be reprinted in its entirety without any changes.
• Entities shall not publish excerpts without AHRQ review and approval.
• For AHRQ-approved excerpts, use the following citation.

abrir aquí para acceder al archivo PDF de 111 páginas (680 Kb):
http://www.cms.hhs.gov/determinationprocess/downloads/id64TA.pdf